Health on TIME.com
Genetic Testing Company 23andMe Finds New Revenue with Big Pharma
The company’s database of genetic information is worth $10 million to Genentech
Published on January 9, 2015 at 06:04AM
Shared at 0 shares/hour
Read more: http://ift.tt/1DqFzBx
No comments:
Post a Comment